Opinion

This AI open-source cloning software shows the gaping hole in code copyright

And the funny thing is, it seems like it's completely legal.
Yahoo Finance

Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

Preparations underway to advance AP-101 into confirmatory Phase 3 clinical trial with initiation aimed for late 2026 ZURICH, March 19, 2026--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage ...
PharmiWeb

Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

Preparations underway to advance AP-101 into confirmatory Phase 3 clinical trial with initiation aimed for late 2026 ZURICH--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage biotechnology company ...
Business Wire

Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

ZURICH--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis ...
Las Vegas Sun

Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the ...
Finanznachrichten

EQS-News: AL-S Pharma AG: Additional Phase 2 Data of AL-S Pharma's Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

EQS-News: AL-S Pharma AG / Key word (s): Study results Additional Phase 2 Data of AL-S Pharma's Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification ...
The Maravi Post

Brazil inflicts heavy defeat on Zambia in 2026 FIFA Women’s World Cup

LUSAKA-(MaraviPost)-Zambia suffered a second consecutive defeat in the FIFA Women’s World Cup, succumbing to a 6-1 thrashing ...
Yahoo Finance

AviadoBio Advances AVB-101 Gene Therapy Program and Initiates Fourth Dose-Escalation Cohort of Phase 1/2 ASPIRE-FTD Trial

LONDON, March 31, 2026--(BUSINESS WIRE)--AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today ...
WFTV

Disney Musicals in Schools program culminates in Endeavour Elementary’s ’101 Dalmatians KIDS’

BREVARD COUNTY, Fla. — Endeavour Elementary students will perform “101 Dalmatians KIDS” on Thursday at the Rockledge High School Auditorium. The event marks the culmination of a unique partnership ...
Metro Weekly

Spring Arts Preview 2026: Comedy, Exhibits, and Everything Else

From author talks and exhibitions to festivals, lectures, and offbeat events, here’s your guide to the DMV’s most eclectic spring offerings.
Hartford Courant

UConn women’s basketball sets program record with 20 3-pointers in 101-68 rout of Iowa State

UNCASVILLE — The UConn women’s basketball team dominated Iowa State 101-68 in the Basketball Hall of Fame Showcase on Tuesday night, setting a program record with 20 made 3-pointers in their ...
City A.M.

AviadoBio Advances AVB-101 Gene Therapy Program and Initiates Fourth Dose-Escalation Cohort of Phase 1/2 ASPIRE-FTD Trial

AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today announced that the company has initiated ...